Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 1,837-1,848 of 4,306
Behavioral study icon
Not recruitingISRCTN08387324

Evaluation of a Peer-Led Self-Management Programme (PLSMP) for people with schizophrenia

This study is looking at whether psychoeducation can help people with Psychiatry/schizophrenia/rehabilitation, Mental and Behavioural Disorders, or Schizophrenia. Participants take part in psychoeducation and complete follow-up assessments.

In Singapore
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaOther
Countries
Singapore
Sponsor
National University of Singapore (Singapore)
Condition
Schizophrenia
Drug study icon
Not recruitingEUCTR 2010-024119-15

EVALUATION OF THE EFFICACY OF TOLCAPONE AS A GENOTYPE-BASED TARGETED COGNITIVE ENHANCER IN SCHIZOPHRENIA, BASED ON THE POLYMORPHISM RS4680

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Pamplona
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugA study involving a medication or substance.
Countries
Spain
Sponsor
Clínica Universidad de Navarra/Universidad de Navarra
Condition
Schizophrenia
Drug study icon
Not recruitingEUCTR 2018-002708-15

Interventional, open-label, flexible-dose, long-term safety extension study of Lu AF11167 in patients with schizophrenia

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Bulgaria
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrug
Countries
Bulgaria, Czechia, Germany, ...
Sponsor
H. Lundbeck A/S
Condition
Schizophrenia
Drug study icon
Not recruitingEUCTR 2011-004327-13

Long-Term Open-Label Safety Study of Pomaglumetad Methionil in Patients with Schizophrenia

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Austria
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrug
Countries
Belgium, Austria, Germany, ...
Sponsor
Eli Lilly and Company
Condition
Schizophrenia
Behavioral study icon
Not recruitingISRCTN72416821

Modernising teams service delivery: implementing the NICE schizophrenia guideline

This study is looking at whether Cluster randomised trial of a training and implementation programme of the NICE guideline across community mental health teams in SLaM can help people with Mental and Behavioural Disorders: Schizophrenia, Mental and Behavioural Disorders, or Schizophrenia. Participants take part in Cluster randomised trial of a training and implementation programme of the NICE guideline across community mental health teams in SLaM and complete follow-up assessments.

In United Kingdom
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaOther
Countries
United Kingdom
Sponsor
Department of Health
Condition
Schizophrenia
Drug study icon
Not recruitingEUCTR 2009-014469-19

OCTUMI-4: Evaluation of Mirtazapine and Folic Acid for Schizophrenia: A randomised, double-blind, 2x2 factorial trial

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Finland
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrug
Countries
United Kingdom, Finland, Italy
Sponsor
University of Oxford [...] 1. University of Oxford 2.
Condition
Schizophrenia
Drug study icon
Not recruitingEUCTR 2005-004383-23

Pragmatic randomized trial of Risperdal Consta versus oral atypical antipsychotics in poorly adherent subjects with schizophrenia ina routine care setting. Protocol RISSCH4055; Phase IV (risperid...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Ireland
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrug
Countries
United Kingdom, Ireland
Sponsor
Janssen Cilag Ltd
Condition
Schizophrenia
Other study type icon
Not recruitingISRCTN62348361

Effectiveness of shared care between GP and secondary services in Schizophrenia

This study is not recruiting in the United Kingdom. It is testing shared care between GP and secondary services for Schizophrenia.

In United Kingdom
Why is this study shown?

This study is directly about Schizophrenia.

Schizophrenia, Depression, ...Other
Countries
United Kingdom
Sponsor
NHS R&D Regional Programme Register - Department of Health (UK)
Condition
Schizophrenia, Depression, ...
Other study type icon
Not recruitingISRCTN37724980

Walk this Way: a study investigating the effect of a motivational pedometer based walking intervention to reduce sedentary behaviour and increase activity levels of people with serious mental illness

This study is not recruiting in the United Kingdom. It focuses on Schizophrenia.

In United Kingdom
Why is this study shown?

This study is directly about Schizophrenia.

Schizophrenia, Bipolarity, ...Other
Countries
United Kingdom
Sponsor
King's College London
Condition
Schizophrenia, Bipolarity, ...
Behavioral study icon
Not recruitingISRCTN14763786

Walking improves the cognitive function of schizophrenic subjects

This study is looking at a support or therapy approach for people with Schizophrenia or Mental and Behavioural Disorders. Participants take part in the program or support approach and complete follow-up assessments.

In Italy
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaOther
Countries
Italy
Sponsor
University of Ferrara
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.